ML13150A280

Shine Medical Technologies, Inc. - Cover Letter for Notice of Acceptance for Docketing of Part One of an Application for a Construction Permit Under 10 CFR Part 50

ML13150A280
Person / Time
Site:	SHINE Medical Technologies, PROJ0792
Issue date:	06/25/2013
From:	Steven Lynch Research and Test Reactors Licensing Branch
To:	Bynum R SHINE Medical Technologies
Lynch, S
Shared Package
ML13150A276	List: ML13150A280 ML13150A389
References
TAC ME7820
Download: ML13150A280 (4)

Text

June 25, 2013 Richard Vann Bynum, PhD Chief Operating Officer SHINE Medical Technologies, Inc 2555 Industrial Drive Monona, WI 53713

SUBJECT:

SHINE MEDICAL TECHNOLOGIES, INC. - ACCEPTANCE FOR DOCKETING OF PART ONE OF THE APPLICATION FOR CONSTRUCTION PERMIT (TAC NO. ME7820)

Dear Dr. Bynum:

By letter dated March 26, 2013 (SMT-2013-012, Agencywide Documents Access and Management System (ADAMS) Accession No. ML13088A192), SHINE Medical Technologies, Inc. (SHINE) submitted part one of an application for a construction permit, which, if granted, would allow SHINE to construct a medical radioisotope production facility to be located in Janesville, Wisconsin.

The U.S. Nuclear Regulatory Commission (NRC) staff acknowledged receipt of part one of SHINEs two-part application for a construction permit under Title 10 of the Code of Federal Regulations (10 CFR), Part 50 in the Federal Register (78 FR 29390) on May 20, 2013. An exemption from certain requirements of 10 CFR 2.101(a)(5) granted by the Commission on March 20, 2013 (ADAMS Accession No. ML13072B195), in response to a letter from SHINE dated February 18, 2013 (ADAMS Accession No. ML13051A007), allowed for SHINE to submit its construction permit application in two parts. Specifically, the exemption allowed SHINE to submit a portion of its application for a construction permit up to six months prior to the remainder of the application regardless of whether or not an environmental impact statement or a supplement to an environmental impact statement is prepared during the review of its application. In accordance with 10 CFR 2.101(a)(5), SHINE submitted the following in part one of its construction permit application:

• the description and safety assessment of the site required by 10 CFR 50.34(a)(1)

• the environmental report required by 10 CFR 50.30(f)

• the filing fee information required by 10 CFR 50.30(e) and 10 CFR 170.21

• the general information required by 10 CFR 50.33

• the agreement limiting access to classified information required by 10 CFR 50.37 As stated in SHINEs March 26, 2013, letter, part two of SHINEs application for a construction permit will contain the remainder of the preliminary safety analysis report required by 10 CFR 50.34(a) and will be submitted in accordance with the requirements of 10 CFR 2.101(a)(5).

The NRC staff has reviewed part one of SHINEs application for a construction permit and determined that the submitted portion of the application is complete and acceptable for docketing. The docket number assigned to this project is 50-608. Please reflect this docket

R. Vann Bynum number on all future correspondence. A separate completeness and acceptability review will be performed upon receipt of part two of SHINEs application for a construction permit.

Enclosed is the notice that will be forwarded to the Federal Register, informing the public of the docketing of part one of SHINEs application for a construction permit.

The NRC staff intends to publish a review schedule for SHINEs construction permit application following the completion of the acceptance review for part two of the application.

If you have any questions, please contact me at Steven.Lynch@nrc.gov or 301-415-1524.

Sincerely,

/RA/

Steven Lynch, Project Manager Research and Test Reactors Licensing Branch Division of Policy and Rulemaking Office of Nuclear Reactor Regulation Docket No.: 50-608

Enclosure:

Federal Register Notice cc w/ encl.: See next page

cc:

Jim Costedio Bill McCoy Licensing Manager 1326 Putnam Avenue SHINE Medical Technologies, Inc. Janesville, WI 53546 2555 Industrial Drive Monona, WI 53713 Alfred Lembrich 541 Miller Avenue Cindy Atkins-Duffin, Ph.D. Janesville, WI 53548 Senior Policy Analyst Office of Science and Technology Policy Gerald and Muriel Bumgarner Executive Office Building 1735 S Osborne Ave 1650 Pennsylvania Avenue Janesville, WI 53546 Washington, D.C. 20503 Joan Dix National Nuclear Security Administration, NA-212 U.S. Department of Energy 1000 Independence Ave SW Washington, DC 20585 Cheryl Rogers Supervisor Radiation Protection Section Wisconsin Department of Health Services P.O. Box 2659 Madison, WI 53701-2659 Amanda Cushman Environmental Analysis and Review Specialist State of Wisconsin Department of Natural Resources 3911 Fish Hatchery Road Fitchburg, WI 53711 TRTR Newsletter University of Florida Department of Nuclear Engineering Sciences 202 Nuclear Sciences Center Gainesville, FL 32611 Eric Levitt City Manager P.O. Box 5005 Janesville, WI 53547-5005

Pkg: ML13150A276 Letter: ML13150A280 FRN: ML13150A389 Memo to ADM: ML13150A390 *concurrence via e-mail ADM-012 OFFICE NRR/PRLB/PM NRR/DPR/LA OGC NRR/RERB/BC NRR/PRLB/BC NRR/PRLB/PM NAME SLynch CHawes CMH JBiggins* (NLO) MWong AAdams SLynch DATE 6/7/13 6/11/13 6/14/13 6/24/13 6/25/13 6/25/13